BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011;16:79-88. [PMID: 21435084 DOI: 10.1111/j.1523-5378.2011.00822.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 131] [Article Influence: 11.2] [Reference Citation Analysis]
Number Citing Articles
1 Franceschi F, Gasbarrini A, Polyzos SA, Kountouras J. Extragastric Diseases and Helicobacter pylori. Helicobacter. 2015;20 Suppl 1:40-46. [PMID: 26372824 DOI: 10.1111/hel.12256] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 13.3] [Reference Citation Analysis]
2 Chung GE, Heo NJ, Park MJ, Chung SJ, Kang HY, Kang SJ. Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World J Gastroenterol 2013; 19(1): 97-102 [PMID: 23326169 DOI: 10.3748/wjg.v19.i1.97] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
3 Polyzos SA, Kountouras J, Zavos C, Deretzi G. Helicobacter pylori Infection and insulin resistance. Helicobacter 2013;18:165-6. [PMID: 23066701 DOI: 10.1111/hel.12019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 Christodoulou DK, Milionis HJ, Tsianos EV. Helicobacter pylori as a risk factor for cardiovascular disease: Is it or is it not? European Journal of Internal Medicine 2011;22:e148. [DOI: 10.1016/j.ejim.2011.06.001] [Reference Citation Analysis]
5 Yu YY, Cai JT, Song ZY, Tong YL, Wang JH. The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population. Medicine (Baltimore) 2018;97:e13271. [PMID: 30431613 DOI: 10.1097/MD.0000000000013271] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
6 He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: Is it a myth or fact? World J Gastroenterol 2014; 20(16): 4607-4617 [PMID: 24782613 DOI: 10.3748/wjg.v20.i16.4607] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
7 Tsay FW, Hsu PI. H. pylori infection and extra-gastroduodenal diseases. J Biomed Sci. 2018;25:65. [PMID: 30157866 DOI: 10.1186/s12929-018-0469-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
8 Polyzos SA, Kountouras J. Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology. Journal of Clinical Gastroenterology 2019;53:624-6. [DOI: 10.1097/mcg.0000000000001218] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Hidaka A, Sasazuki S, Goto A, Sawada N, Shimazu T, Yamaji T, Iwasaki M, Inoue M, Noda M, Tajiri H. Plasma insulin, C-peptide and blood glucose and the risk of gastric cancer: the Japan Public Health Center-based prospective study. Int J Cancer. 2015;136:1402-1410. [PMID: 25066446 DOI: 10.1002/ijc.29098] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
10 Hagymási K, Tulassay Z. Helicobacter pylori infection: New pathogenetic and clinical aspects. World J Gastroenterol 2014; 20(21): 6386-6399 [PMID: 24914360 DOI: 10.3748/wjg.v20.i21.6386] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
11 Liou JM, Chen CC, Chang CM, Fang YJ, Bair MJ, Chen PY, Chang CY, Hsu YC, Chen MJ, Lee JY, Yang TH, Luo JC, Chen CY, Hsu WF, Chen YN, Wu JY, Lin JT, Lu TP, Chuang EY, El-Omar EM, Wu MS;  Taiwan Gastrointestinal Disease and Helicobacter Consortium. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. Lancet Infect Dis. 2019;19:1109-1120. [PMID: 31559966 DOI: 10.1016/s1473-3099(19)30272-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 23] [Article Influence: 21.5] [Reference Citation Analysis]
12 Chen LW, Chien CY, Yang KJ, Kuo SF, Chen CH, Chien RN. Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study. PLoS One 2015;10:e0128671. [PMID: 26020514 DOI: 10.1371/journal.pone.0128671] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
13 Kountouras J, Polyzos SA, Katsinelos P, Doulberis M, Zavos C, Kazakos E, Boziki M, Tzivras D, Kotronis G. Letter : Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017;46:637-8. [DOI: 10.1111/apt.14222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
14 Kountouras J, Doulberis M, Papaefthymiou A, Polyzos SA, Vardaka E, Tzivras D, Dardiotis E, Deretzi G, Giartza‐taxidou E, Grigoriadis S, Katsinelos P. A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection. Ann N Y Acad Sci 2019;1452:12-7. [DOI: 10.1111/nyas.14168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
15 Chen TP, Hung HF, Chen MK, Lai HH, Hsu WF, Huang KC, Yang KC. Helicobacter Pylori Infection is Positively Associated with Metabolic Syndrome in Taiwanese Adults: a Cross-Sectional Study. Helicobacter 2015;20:184-91. [PMID: 25582223 DOI: 10.1111/hel.12190] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
16 Polyzos SA, Zeglinas C, Artemaki F, Doulberis M, Kazakos E, Katsinelos P, Kountouras J. Helicobacter pylori infection and esophageal adenocarcinoma: a review and a personal view. Ann Gastroenterol 2018;31:8-13. [PMID: 29333062 DOI: 10.20524/aog.2017.0213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
17 Alvarez CS, Florio AA, Butt J, Rivera-Andrade A, Kroker-Lobos MF, Waterboer T, Camargo MC, Freedman ND, Graubard BI, Lazo M, Guallar E, Groopman JD, Ramírez-Zea M, McGlynn KA. Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala. Helicobacter 2020;25:e12756. [PMID: 33006810 DOI: 10.1111/hel.12756] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017;71:182-97. [DOI: 10.1016/j.metabol.2017.03.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 13.4] [Reference Citation Analysis]
19 Tian XP, Jiang FQ, Cui Y. Association of Helicobacter pylori infection with type 2 diabetes. Shijie Huaren Xiaohua Zazhi 2016; 24(34): 4555-4561 [DOI: 10.11569/wcjd.v24.i34.4555] [Reference Citation Analysis]
20 Li M, Shen Z, Li YM. Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease. World J Gastroenterol 2013; 19(41): 7024-7031 [PMID: 24222944 DOI: 10.3748/wjg.v19.i41.7024] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
21 Doulberis M, Pierre NT, Manzini G, Papaefthymiou A, Kountouras J, Klukowska-Rötzler J, Polyzos SA, Srivastava S, Exadaktylos AK, Knuchel J, Kuntzen T, Srivastava DS. Helicobacter pylori-Related Metabolic Parameters and Premalignant Gastric Mucosa Histological Lesions in Swiss Bariatric Patients. Microorganisms 2021;9:1361. [PMID: 34201748 DOI: 10.3390/microorganisms9071361] [Reference Citation Analysis]
22 Zhou X, Liu W, Gu M, Zhou H, Zhang G. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway. J Gastroenterol. 2015;50:1027-1040. [PMID: 25689935 DOI: 10.1007/s00535-015-1051-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
23 Polyzos SA, Papaefthymiou A, Doulberis M, Mavridoglou G, Kountouras J. Helicobacter pylori infection and diabetes mellitus. Diabetes Metab Syndr 2021;15:845-6. [PMID: 33873053 DOI: 10.1016/j.dsx.2021.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Chen LW, Chien CY, Hsieh CW, Chang LC, Huang MH, Huang WY, Kuo SF, Chien CH, Lin CL, Chien RN. The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study. Medicine (Baltimore) 2016;95:e3616. [PMID: 27149497 DOI: 10.1097/MD.0000000000003616] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
25 Du Y, Heidemann C, Gößwald A, Schmich P, Scheidt-Nave C. Prevalence and comorbidity of diabetes mellitus among non-institutionalized older adults in Germany - results of the national telephone health interview survey 'German Health Update (GEDA)' 2009. BMC Public Health 2013;13:166. [PMID: 23433228 DOI: 10.1186/1471-2458-13-166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
26 Vafaeimanesh J, Heidari A, Effatpanah M, Parham M. Serum adiponectin level in diabetic patients with and without Helicobacter pylori infection: is there any difference? ScientificWorldJournal 2014;2014:402685. [PMID: 24523637 DOI: 10.1155/2014/402685] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Peng YL, Leu HB, Luo JC, Huang CC, Hou MC, Lin HC, Lee FY. Diabetes is an independent risk factor for peptic ulcer bleeding: a nationwide population-based cohort study. J Gastroenterol Hepatol. 2013;28:1295-1299. [PMID: 23488965 DOI: 10.1111/jgh.12190] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
28 Polyzos SA, Kountouras J. Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy. Helicobacter 2019;24:e12588. [DOI: 10.1111/hel.12588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
29 Castaño-Rodríguez N, Mitchell HM, Kaakoush NO. NAFLD, Helicobacter species and the intestinal microbiome. Best Pract Res Clin Gastroenterol 2017;31:657-68. [PMID: 29566909 DOI: 10.1016/j.bpg.2017.09.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
30 Shen Z, Qin Y, Liu Y, Lu Y, Munker S, Chen L, Yu C, Chen P, Li Y. Helicobacter pylori infection is associated with the presence of thyroid nodules in the euthyroid population. PLoS One. 2013;8:e80042. [PMID: 24244604 DOI: 10.1371/journal.pone.0080042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
31 Zhou M, Liu J, Qi Y, Wang M, Wang Y, Zhao F, Hao Y, Zhao D. The association between Helicobacter pylori seropositivity and risk of new-onset diabetes: a prospective cohort study. Diabetologia 2018;61:300-7. [PMID: 29085991 DOI: 10.1007/s00125-017-4465-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
32 Kountouras J, Polyzos SA, Kapetanakis N, Katsinelos P, Nikolopoulos P, Stogianni A, Kazakos E, Zeglinas C, Stefanidis E, Romiopoulos I, Tzivras D, Boziki M, Dardiotis E, Deretzi G. Letter: Helicobacter pylori -related non-alcoholic fatty liver disease with concomitant metabolic syndrome as risk factor for colorectal neoplasia. Aliment Pharmacol Ther 2017;45:576-7. [DOI: 10.1111/apt.13900] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
33 Korbel L, Easterling RS, Punja N, Spencer JD. The burden of common infections in children and adolescents with diabetes mellitus: A Pediatric Health Information System study. Pediatr Diabetes 2018;19:512-9. [PMID: 29094435 DOI: 10.1111/pedi.12594] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
34 Kountouras J, Polyzos SA, Deretzi G, Katsinelos P, Kyriakou P. Helicobacter pylori infection and the risk for cardiovascular disease. European Journal of Internal Medicine 2011;22:e146-7. [DOI: 10.1016/j.ejim.2011.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kountouras J, Polyzos SA, Doulberis M, Zeglinas C, Artemaki F, Vardaka E, Deretzi G, Giartza-Taxidou E, Tzivras D, Vlachaki E, Kazakos E, Katsinelos P, Mantzoros CS. Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis. Metabolism 2018;87:18-24. [PMID: 29936174 DOI: 10.1016/j.metabol.2018.06.008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
36 Bonfigli AR, Boemi M, Festa R, Bonazzi P, Brandoni G, Spazzafumo L, Olivieri F, Ceriello A, Genovese S, Testa R. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2016;26:893-8. [PMID: 27480449 DOI: 10.1016/j.numecd.2016.06.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
37 Franceschi F, Tortora A, Di Rienzo T, D’Angelo G, Ianiro G, Scaldaferri F, Gerardi V, Tesori V, Lopetuso LR, Gasbarrini A. Role of Helicobacter pylori infection on nutrition and metabolism. World J Gastroenterol 2014; 20(36): 12809-12817 [PMID: 25278679 DOI: 10.3748/wjg.v20.i36.12809] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
38 Vafaeimanesh J, Parham M, Seyyedmajidi M, Bagherzadeh M. Helicobacter pylori infection and insulin resistance in diabetic and nondiabetic population. ScientificWorldJournal. 2014;2014:391250. [PMID: 25405220 DOI: 10.1155/2014/391250] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
39 Rabelo-Gonçalves EM, Roesler BM, Zeitune JM. Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases. World J Hepatol 2015; 7(30): 2968-2979 [PMID: 26730276 DOI: 10.4254/wjh.v7.i30.2968] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
40 Delitala AP, Pes GM, Malaty HM, Pisanu G, Delitala G, Dore MP. Implication of Cytotoxic Helicobacter pylori Infection in Autoimmune Diabetes. J Diabetes Res 2016;2016:7347065. [PMID: 26824048 DOI: 10.1155/2016/7347065] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
41 Rahman MM, Kibria MG, Sultana N, Akhter M, Begum H, Haque MA, Haque R, Sarker SA, Ahmed F, Hasan M. Seroprevalence of Helicobacter pylori and its association with metabolic syndrome in a rural community of Bangladesh. JGH Open 2021;5:64-72. [PMID: 33490615 DOI: 10.1002/jgh3.12448] [Reference Citation Analysis]
42 Wang J, Dong F, Su H, Zhu L, Shao S, Wu J, Liu H. H. pylori is related to NAFLD but only in female: A Cross-sectional Study. Int J Med Sci 2021;18:2303-11. [PMID: 33967606 DOI: 10.7150/ijms.50748] [Reference Citation Analysis]
43 Vijayvergiya R, Vadivelu R. Role of Helicobacter pylori infection in pathogenesis of atherosclerosis. World J Cardiol 2015; 7(3): 134-143 [PMID: 25810813 DOI: 10.4330/wjc.v7.i3.134] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
44 Kachuei A, Amini M, Sebghatollahi V, Feizi A, Hamedani P, Iraj B. Effect of Helicobacter pylori eradication on insulin resistance among prediabetic patients: A pilot study and single-blind randomized controlled clinical trial. J Res Med Sci 2016;21:8. [PMID: 27904554 DOI: 10.4103/1735-1995.177355] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
45 Zhang YF, Zhao ZF, Li ZH, Qi HB, Guo SQ, Zhu CY. Relationship between Helicobacter pylori infection and type 2 diabetic fatty liver. Shijie Huaren Xiaohua Zazhi 2016; 24(23): 3533-3536 [DOI: 10.11569/wcjd.v24.i23.3533] [Reference Citation Analysis]
46 Kato M, Toda A, Yamamoto-Honda R, Arase Y, Sone H. Association between Helicobacter pylori infection, eradication and diabetes mellitus. J Diabetes Investig 2019;10:1341-6. [PMID: 30663265 DOI: 10.1111/jdi.13011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Doğan Z, Filik L, Ergül B, Sarikaya M, Akbal E. Association between Helicobacter pylori and liver-to-spleen ratio: a randomized-controlled single-blind study. Eur J Gastroenterol Hepatol 2013;25:107-10. [PMID: 23013624 DOI: 10.1097/MEG.0b013e3283590c10] [Cited by in Crossref: 30] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
48 Xu C, Yan M, Sun Y, Joo J, Wan X, Yu C, Wang Q, Shen C, Chen P, Li Y, Coleman WG Jr. Prevalence of Helicobacter pylori infection and its relation with body mass index in a Chinese population. Helicobacter 2014;19:437-42. [PMID: 25256639 DOI: 10.1111/hel.12153] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
49 Polyzos SA, Kountouras J, Zavos C, Deretzi G. Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012; 35: 520-525. Diabetes Care. 2012;35:e53; author reply e54. [PMID: 22723589 DOI: 10.2337/dc12-0248] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Zhang FM, Yu CH, Chen HT, Shen Z, Hu FL, Yuan XP, Xu GQ. Helicobacter pylori infection is associated with gallstones: Epidemiological survey in China. World J Gastroenterol 2015; 21(29): 8912-8919 [PMID: 26269681 DOI: 10.3748/wjg.v21.i29.8912] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
51 Bahadoran Z, Mirmiran P, Yeganeh MZ, Hosseinpanah F, Zojaji H, Azizi F. Complementary and alternative medicinal effects of broccoli sprouts powder on Helicobacter pylori eradication rate in type 2 diabetic patients: A randomized clinical trial. Journal of Functional Foods 2014;7:390-7. [DOI: 10.1016/j.jff.2014.01.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.6] [Reference Citation Analysis]
52 Singh SP, Konwarh R, Konwar BK, Karak N. Molecular docking studies on analogues of quercetin with d-alanine:d-alanine ligase of Helicobacter pylori. Med Chem Res 2013;22:2139-50. [DOI: 10.1007/s00044-012-0207-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Buzás GM. Metabolic consequences of Helicobacter pylori infection and eradication. World J Gastroenterol 2014; 20(18): 5226-5234 [PMID: 24833852 DOI: 10.3748/wjg.v20.i18.5226] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
54 Cohen D, Muhsen K. Association between Helicobacter pylori colonization and glycated hemoglobin levels: is this another reason to eradicate H. pylori in adulthood? J Infect Dis. 2012;205:1183-1185. [PMID: 22427675 DOI: 10.1093/infdis/jis110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
55 Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Koike K. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. World J Gastroenterol 2018; 24(32): 3617-3625 [PMID: 30166857 DOI: 10.3748/wjg.v24.i32.3617] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
56 Polyzos SA, Nikolopoulos P, Stogianni A, Romiopoulos I, Katsinelos P, Kountouras J. EFFECT OF HELICOBACTER PYLORI ERADICATION ON HEPATIC STEATOSIS, NAFLD FIBROSIS SCORE AND HSENSI IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: a MR imaging-based pilot open-label study. Arq Gastroenterol 2014;51:261-8. [DOI: 10.1590/s0004-28032014000300017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
57 Mantovani A, Turino T, Altomari A, Lonardo A, Zoppini G, Valenti L, Tilg H, Byrne CD, Targher G. Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis. Metabolism 2019;96:56-65. [DOI: 10.1016/j.metabol.2019.04.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
58 Alshareef SA, Rayis DA, Adam I, Gasim GI. Helicobacter pylori infection, gestational diabetes mellitus and insulin resistance among pregnant Sudanese women. BMC Res Notes 2018;11:517. [PMID: 30055649 DOI: 10.1186/s13104-018-3642-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
59 Hegazy WAH, Rajab AAH, Abu Lila AS, Abbas HA. Anti-diabetics and antimicrobials: Harmony of mutual interplay. World J Diabetes 2021; 12(11): 1832-1855 [PMID: 34888011 DOI: 10.4239/wjd.v12.i11.1832] [Reference Citation Analysis]
60 Wang LP, Peng XY, Lv XQ, Liu L, Li XL, He X, Lv F, Pan Y, Wang L, Liu KF, Zhang XM. High throughput circRNAs sequencing profile of follicle fluid exosomes of polycystic ovary syndrome patients. J Cell Physiol 2019. [PMID: 30779115 DOI: 10.1002/jcp.28201] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
61 Kim TJ, Lee H, Kang M, Kim JE, Choi YH, Min YW, Min BH, Lee JH, Son HJ, Rhee PL, Baek SY, Ahn SH, Kim JJ. Helicobacter pylori is associated with dyslipidemia but not with other risk factors of cardiovascular disease. Sci Rep 2016;6:38015. [PMID: 27892538 DOI: 10.1038/srep38015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
62 Alberts CJ, Jeske R, de Martel C, den Hollander WJ, Michel A, Prins M, Snijder MB, Schim van der Loeff MF, Waterboer T. Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS study. Helicobacter 2020;25:e12687. [PMID: 32147867 DOI: 10.1111/hel.12687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
63 He C, Cheng D, Wang H, Wu K, Zhu Y, Lu N. Helicobacter pylori infection aggravates diet-induced nonalcoholic fatty liver in mice. Clinics and Research in Hepatology and Gastroenterology 2018;42:360-7. [DOI: 10.1016/j.clinre.2017.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
64 Chen LW, Chien CH, Lin CL, Chien RN. Increased Glycated Hemoglobin but Decreased Cholesterol after a Loss of Helicobacter pylori Infection: A Community-Based Longitudinal Metabolic Parameters Follow-Up Study. J Pers Med 2021;11:997. [PMID: 34683138 DOI: 10.3390/jpm11100997] [Reference Citation Analysis]
65 Dogan Z, Sarikaya M, Ergul B, Filik L. The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:242-245. [PMID: 24993741 DOI: 10.5507/bp.2014.036] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
66 Sumida Y, Kanemasa K, Imai S, Mori K, Tanaka S, Shimokobe H, Kitamura Y, Fukumoto K, Kakutani A, Ohno T, Taketani H, Seko Y, Ishiba H, Hara T, Okajima A, Yamaguchi K, Moriguchi M, Mitsuyoshi H, Yasui K, Minami M, Itoh Y. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. J Gastroenterol 2015;50:996-1004. [PMID: 25622927 DOI: 10.1007/s00535-015-1039-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
67 Chmiela M, Gajewski A, Rudnicka K. Helicobacter pylori vs coronary heart disease - searching for connections. World J Cardiol 2015; 7(4): 187-203 [PMID: 25914788 DOI: 10.4330/wjc.v7.i4.187] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
68 Kountouras J, Polyzos SA, Katsinelos P, Zeglinas C, Artemaki F, Tzivras D, Vardaka E, Gavalas E, Romiopoulos I, Simeonidou C, Grigoriadis N, Kountouras C, Dardiotis E, Deretzi G. Cardio-cerebrovascular disease and Helicobacter pylori-related metabolic syndrome: We consider eradication therapy as a potential cardio-cerebrovascular prevention strategy. International Journal of Cardiology 2017;229:17-8. [DOI: 10.1016/j.ijcard.2016.11.265] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
69 Tang B, Tang L, Huang C, Tian C, Chen L, He Z, Yang G, Zuo L, Zhao G, Liu E, Wang S, Lin H, He J, Yang S. The Effect of Probiotics Supplementation on Gut Microbiota After Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial.Infect Dis Ther. 2021;10:317-333. [PMID: 33270205 DOI: 10.1007/s40121-020-00372-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Banić M, Franceschi F, Babić Z, Gasbarrini A. Extragastric Manifestations of Helicobacter pylori Infection. Helicobacter 2012;17:49-55. [DOI: 10.1111/j.1523-5378.2012.00983.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 4.5] [Reference Citation Analysis]
71 Baeg MK, Yoon SK, Ko SH, Noh YS, Lee IS, Choi MG. Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease. World J Gastroenterol 2016; 22(8): 2592-2600 [PMID: 26937147 DOI: 10.3748/wjg.v22.i8.2592] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
72 Dai YN, Yu WL, Zhu HT, Ding JX, Yu CH, Li YM. Is Helicobacter pylori infection associated with glycemic control in diabetics? World J Gastroenterol 2015; 21(17): 5407-5416 [PMID: 25954115 DOI: 10.3748/wjg.v21.i17.5407] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
73 Mohammadifard M, Saremi Z, Rastgoo M, Akbari E. Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran. J Med Life 2019;12:168-72. [PMID: 31406519 DOI: 10.25122/jml-2019-0012] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
74 Liou JM, Lee YC, El-Omar EM, Wu MS. Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention. Cancers (Basel) 2019;11:E593. [PMID: 31035365 DOI: 10.3390/cancers11050593] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
75 Buzás GM. Helicobacter pylori and non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2020;66:267-79. [PMID: 32724031 DOI: 10.23736/S1121-421X.20.02671-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
76 Cheng KP, Yang YJ, Hung HC, Lin CH, Wu CT, Hung MH, Sheu BS, Ou HY. Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection. J Diabetes Investig. 2019;10:1092-1101. [PMID: 30556347 DOI: 10.1111/jdi.12991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
77 Kountouras J, Zavos C, Giorgakis N, Tantsi N, Kotsani M. Additional data on Helicobacter pylori and hepatitis C virus infections and lymphoma association. Eur J Intern Med 2014;25:e7-8. [PMID: 23651954 DOI: 10.1016/j.ejim.2013.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Wong F, Rayner-Hartley E, Byrne MF. Extraintestinal manifestations of Helicobacter pylori: A concise review. World J Gastroenterol 2014; 20(34): 11950-11961 [PMID: 25232230 DOI: 10.3748/wjg.v20.i34.11950] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
79 Cabrera de León A, Almeida González D, Almeida AA, González Hernández A, Carretero Pérez M, Rodríguez Pérez Mdel C, Guillén VG, Brito Díaz B. Factors associated with parietal cell autoantibodies in the general population. Immunol Lett 2012;147:63-6. [PMID: 22771341 DOI: 10.1016/j.imlet.2012.06.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
80 Xiong F, Xiong M, Ma Z, Huang S, Li A, Liu S. Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study. Gastroenterol Res Pract. 2016;2016:3059201. [PMID: 27493660 DOI: 10.1155/2016/3059201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
81 Yue CY, Yang CZ, Liu CY, Yang Y. Meta-analysis of relationship between Helicobacter pylori infection and level of insulin resistance. Shijie Huaren Xiaohua Zazhi 2015; 23(32): 5238-5249 [DOI: 10.11569/wcjd.v23.i32.5238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Kountouras J, Polyzos SA, Zeglinas C, Tzathas C, Nikolaidis N, Vardaka E, Kountouras C, Anastadiadis S, Anastasiadis K, Giorgakis N, Gavalas E, Tzivras D, Katsinelos P. Helicobacter pylori –related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett’s esophagus cohort. Gastrointestinal Endoscopy 2017;85:462-3. [DOI: 10.1016/j.gie.2016.07.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
83 Cai O, Huang Z, Li M, Zhang C, Xi F, Tan S. Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Single-Center Clinical Study. Gastroenterol Res Pract 2018;2018:8040262. [PMID: 29527224 DOI: 10.1155/2018/8040262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
84 Polyzos SA, Kountouras J, Zavos C, Pyrrou N, Tantsi N. Helicobacter pylori Infection and Serum Adiponectin. Helicobacter 2013;18:321-2. [DOI: 10.1111/hel.12059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
85 Magee MJ, Salindri AD, Gujral UP, Auld SC, Bao J, Haw JS, Lin HH, Kornfeld H. Convergence of non-communicable diseases and tuberculosis: a two-way street? Int J Tuberc Lung Dis 2018;22:1258-68. [PMID: 30355404 DOI: 10.5588/ijtld.18.0045] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
86 Alzahrani S, Nelson J, Moss SF, Paulus JK, Knowler WC, Pittas AG; Diabetes Prevention Program Research Group. H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program. J Diabetes Complications 2017;31:1515-20. [PMID: 28739267 DOI: 10.1016/j.jdiacomp.2017.05.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
87 Polyzos SA, Kountouras J, Mantzoros CS. Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction? Metabolism 2019;96:iii-v. [DOI: 10.1016/j.metabol.2019.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
88 Vafaeimanesh J, Parham M, Bagherzadeh M. Helicobacter pylori infection prevalence: Is it different in diabetics and nondiabetics? Indian J Endocrinol Metab. 2015;19:364-368. [PMID: 25932391 DOI: 10.4103/2230-8210.152773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
89 Lecube A, Valladares S, López-Cano C, Gutiérrez L, Ciudin A, Fort JM, Reñé JM, Matias-Guiu X, de Torres I, Bueno M, Pallarés J, Baena JA. The Role of Morbid Obesity in the Promotion of Metabolic Disruptions and Non-Alcoholic Steatohepatitis by Helicobacter Pylori. PLoS One 2016;11:e0166741. [PMID: 27893763 DOI: 10.1371/journal.pone.0166741] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
90 Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: A review. World J Gastroenterol 2018; 24(29): 3204-3221 [PMID: 30090002 DOI: 10.3748/wjg.v24.i29.3204] [Cited by in CrossRef: 80] [Cited by in F6Publishing: 65] [Article Influence: 20.0] [Reference Citation Analysis]
91 Song X, Cai C, Jin Q, Chen X, Yu C. The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta-analysis. Helicobacter 2021;26:e12781. [PMID: 33465265 DOI: 10.1111/hel.12781] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
92 Yang GQ, Li YJ, Dou JT, Wang BA, Lu JM, Mu YM. Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report. BMC Endocr Disord 2016;16:20. [PMID: 27142369 DOI: 10.1186/s12902-016-0099-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
93 Martin-Nuñez GM, Cornejo-Pareja I, Clemente-Postigo M, Tinahones FJ. Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders? Front Endocrinol (Lausanne) 2021;12:639856. [PMID: 34220702 DOI: 10.3389/fendo.2021.639856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Kang SJ, Kim HJ, Kim D, Ahmed A. Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States. PLoS One 2018;13:e0202325. [PMID: 30110395 DOI: 10.1371/journal.pone.0202325] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
95 Chmiela M, Gonciarz W. Molecular mimicry in Helicobacter pylori infections. World J Gastroenterol 2017; 23(22): 3964-3977 [PMID: 28652651 DOI: 10.3748/wjg.v23.i22.3964] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
96 Zhou B, Yang H, Xu W, Wang K, Guo P, Ai Y. Association between Helicobacter pylori infection and nonalcoholic fatty liver disease: A systematic review and meta‐analysis of observational studies. Helicobacter 2019;24:e12576. [DOI: 10.1111/hel.12576] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
97 Fang LJ, Lin XC, Huang D, Pan TT, Yan XM, Hu WG, Zhu H, Xu Z, Zhu XZ, Lu HJ, Chen GP, Huang KY. 1H NMR-based metabolomics analyses in children with Helicobacter pylori infection and the alteration of serum metabolites after treatment. Microb Pathog 2020;147:104292. [PMID: 32505653 DOI: 10.1016/j.micpath.2020.104292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Matusiak A, Chałubiński M, Broncel M, Rechciński T, Rudnicka K, Miszczyk E, Walencka M, Strapagiel D, Gajewski A, Chmiela M. Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation. Arch Med Sci 2016;12:45-54. [PMID: 26925118 DOI: 10.5114/aoms.2015.50772] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
99 Polyzos SA, Kountouras J, Zavos C, Deretzi G. The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance. Clinics (Sao Paulo). 2011;66:911-912. [PMID: 21789399 DOI: 10.1590/s1807-59322011000500031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
100 Vafaeimanesh J, Rajabzadeh R, Ahmadi A, Moshtaghi M, Banikarim S, Hajiebrahimi S, Seyyedmajidi M. Effect of Helicobacter pylori eradication on glycaemia control in patients with type 2 diabetes mellitus and comparison of two therapeutic regimens. Arab J Gastroenterol. 2013;14:55-58. [PMID: 23820501 DOI: 10.1016/j.ajg.2013.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
101 Polyzos SA, Kountouras J, Zavos C, Deretzi G. Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact. Saudi J Gastroenterol 2011;17:425-6. [PMID: 22064347 DOI: 10.4103/1319-3767.87190] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Waluga M, Kukla M, Żorniak M, Bacik A, Kotulski R. From the stomach to other organs: Helicobacter pylori and the liver. World J Hepatol 2015; 7(18): 2136-2146 [PMID: 26328025 DOI: 10.4254/wjh.v7.i18.2136] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
103 Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017; 23(9): 1521-1540 [PMID: 28321154 DOI: 10.3748/wjg.v23.i9.1521] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
104 Hughes BL, Clifton RG, Hauth JC, Leveno KJ, Myatt L, Reddy UM, Varner MW, Wapner RJ, Mercer BM, Peaceman AM, Ramin SM, Tolosa JE, Saade G, Sorokin Y; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Is Mid-trimester Insulin Resistance Predictive of Subsequent Puerperal Infection? A Secondary Analysis of Randomized Trial Data. Am J Perinatol 2016;33:983-90. [PMID: 27120478 DOI: 10.1055/s-0036-1583188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
105 Doulberis M, Srivastava S, Polyzos SA, Kountouras J, Papaefthymiou A, Klukowska-Rötzler J, Blank A, Exadaktylos AK, Srivastava DS. Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients. J Clin Med 2020;9:E933. [PMID: 32235601 DOI: 10.3390/jcm9040933] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
106 Lim SH, Kim N, Kwon JW, Kim SE, Baik GH, Lee JY, Park KS, Shin JE, Song HJ, Myung D, Choi SC, Kim HJ, Lim JH, Yim JY, Kim JS. Positive Association Between Helicobacter pylori Infection and Metabolic Syndrome in a Korean Population: A Multicenter Nationwide Study. Dig Dis Sci 2019;64:2219-30. [DOI: 10.1007/s10620-019-05544-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
107 Arslan MS, Ekiz F, Deveci M, Sahin M, Topaloglu O, Karbek B, Tutal E, Ginis Z, Cakal E, Ozbek M, Yuksel O, Delibasi T. The relationship between cytotoxin-associated gene A positive Helicobacter pylori infection and autoimmune thyroid disease. Endocr Res 2015;40:211-4. [PMID: 25970504 DOI: 10.3109/07435800.2015.1015727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
108 Li W, Yang Z, Huang DQ, Lv NH. Correlation between Helicobacter pylori infection and hemoglobin A1c expression. Shijie Huaren Xiaohua Zazhi 2012; 20(23): 2179-2183 [DOI: 10.11569/wcjd.v20.i23.2179] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
109 Kountouras J, Polyzos SA, Zeglinas C, Katsinelos P, Giorgakis N, Vardaka E, Kountouras C, Artemaki F, Tzivras D, Kazakos E, Tsiaousi E, Deretzi G. Helicobacter pylori infection and oesophageal adenocarcinoma. Cancer Epidemiology 2016;42:206-7. [DOI: 10.1016/j.canep.2016.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
110 Suki M, Leibovici Weissman Y, Boltin D, Itskoviz D, Tsadok Perets T, Comaneshter D, Cohen A, Niv Y, Dotan I, Leibovitzh H, Levi Z. Helicobacter pylori infection is positively associated with an increased BMI, irrespective of socioeconomic status and other confounders: a cohort study. European Journal of Gastroenterology & Hepatology 2018;30:143-8. [DOI: 10.1097/meg.0000000000001014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
111 Kim TJ, Sinn DH, Min YW, Son HJ, Kim JJ, Chang Y, Baek SY, Ahn SH, Lee H, Ryu S. A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease. J Gastroenterol 2017;52:1201-10. [PMID: 28382402 DOI: 10.1007/s00535-017-1337-y] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
112 Polyzos SA, Kountouras J, Papatheodorou A, Patsiaoura K, Katsiki E, Zafeiriadou E, Zavos C, Anastasiadou K, Terpos E. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism 2013;62:121-6. [DOI: 10.1016/j.metabol.2012.06.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 84] [Article Influence: 9.7] [Reference Citation Analysis]
113 Maev IV, Andreev DN, Kucheryavyi YA. [Helicobacter pylori infection and extragastroduodenal diseases]. Ter Arkh 2015;87:103-10. [PMID: 28635878 DOI: 10.17116/terarkh2015878103-110] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 German SV, Bobrovnitsky IP. [New aspects of Helicobacter pylori infection: Association with metabolic disturbances]. Ter Arkh. 2017;89:102-107. [PMID: 29171479 DOI: 10.17116/terarkh20178910102-107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
115 Gerig R, Ernst B, Wilms B, Thurnheer M, Schultes B. Gastric Helicobacter pylori infection is associated with adverse metabolic traits in severely obese subjects. Obesity (Silver Spring) 2013;21:535-7. [PMID: 23592660 DOI: 10.1002/oby.20098] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
116 Kountouras J, Polyzos SA, Zeglinas C, Katsinelos P. Helicobacter pylori -related chronic hepatitis C infection and the risk for cardiovascular disease. Liver Int 2017;37:1082-1082. [DOI: 10.1111/liv.13161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Polyzos SA, Kountouras J. Novel Advances in the Association Between Helicobacter pylori Infection, Metabolic Syndrome, and Related Morbidity. Helicobacter 2015;20:405-9. [DOI: 10.1111/hel.12228] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
118 Hanauer DA, Ramakrishnan N. Modeling temporal relationships in large scale clinical associations. J Am Med Inform Assoc 2013;20:332-41. [PMID: 23019240 DOI: 10.1136/amiajnl-2012-001117] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
119 Doulberis M, Papaefthymiou A, Srivastava DS, Exadaktylos AK, Katsinelos P, Kountouras J, Polyzos SA. Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection. Int J Clin Pract 2021;75:e13737. [PMID: 32991019 DOI: 10.1111/ijcp.13737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Abenavoli L, Milic N, Masarone M, Persico M. Association between non-alcoholic fatty liver disease, insulin resistance and Helicobacter pylori. Med Hypotheses. 2013;81:913-915. [PMID: 24011768 DOI: 10.1016/j.mehy.2013.08.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
121 Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: Mechanisms for local gastric and systemic effects. World J Gastroenterol 2018; 24(28): 3071-3089 [PMID: 30065554 DOI: 10.3748/wjg.v24.i28.3071] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 45] [Article Influence: 13.3] [Reference Citation Analysis]
122 Kountouras J, Stergiopoulos C, Zavos C. Obstructive Sleep Apnea and Environmental Contributors for Barrett's Esophagus. Clinical Gastroenterology and Hepatology 2014;12:1055-6. [DOI: 10.1016/j.cgh.2013.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Papaefthymiou A, Liatsos C, Georgopoulos SD, Apostolopoulos P, Doulberis M, Kyriakos N, Giakoumis M, Papadomichelakis M, Galanopoulos M, Katsinelos P, Rokkas T, Kountouras J. Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysis. Helicobacter 2020;25:e12666. [PMID: 31692137 DOI: 10.1111/hel.12666] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
124 Kim TJ, Kim ER, Chang DK, Kim YH, Baek SY, Kim K, Hong SN. Helicobacter pylori infection is an independent risk factor of early and advanced colorectal neoplasm. Helicobacter. 2017;22. [PMID: 28124492 DOI: 10.1111/hel.12377] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
125 Abo-Amer YE, Sabal A, Ahmed R, Hasan NFE, Refaie R, Mostafa SM, Mohamed AA, Khalil M, Elagawy W, Abd-Elsalam S. Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study. Diabetes Metab Syndr Obes 2020;13:619-25. [PMID: 32184641 DOI: 10.2147/DMSO.S237866] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
126 Hanafy AS, Seleem WM. Refractory Helicobacter pylori gastritis: The hidden predictors of resistance. Journal of Global Antimicrobial Resistance 2019;19:194-200. [DOI: 10.1016/j.jgar.2019.05.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
127 Stergiopoulos C, Kountouras J, Daskalopoulou-Vlachoyianni E, Polyzos SA, Zavos C, Vlachoyiannis E, Kokkali S, Deretzi G, Kapetanakis N, Katsinelos P, Gavalas E. Helicobacter pylori may play a role in both obstructive sleep apnea and metabolic syndrome. Sleep Med 2012;13:212-3. [PMID: 22137108 DOI: 10.1016/j.sleep.2011.04.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
128 Takeoka A, Tayama J, Yamasaki H, Kobayashi M, Ogawa S, Saigo T, Hayashida M, Shirabe S. Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome. PLoS One 2016;11:e0166588. [PMID: 27851820 DOI: 10.1371/journal.pone.0166588] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
129 Hata K, Koyama T, Ozaki E, Kuriyama N, Mizuno S, Matsui D, Watanabe I, Uehara R, Watanabe Y. Assessing the Relationship between Helicobacter pylori and Chronic Kidney Disease. Healthcare (Basel) 2021;9:162. [PMID: 33546229 DOI: 10.3390/healthcare9020162] [Reference Citation Analysis]
130 Thiyagarajan S, Saini AM, Alruwaili J. Helicobacter pylori-induced autoimmune thyroiditis: is the pathogenic link concluded or still a hypothesis? Reviews in Medical Microbiology 2018;29:64-72. [DOI: 10.1097/mrm.0000000000000133] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
131 Cheng DD, He C, Ai HH, Huang Y, Lu NH. The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. Front Microbiol 2017;8:743. [PMID: 28539915 DOI: 10.3389/fmicb.2017.00743] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
132 Chen LW, Kuo SF, Chen CH, Chien CH, Lin CL, Chien RN. A community-based study on the association between Helicobacter pylori Infection and obesity. Sci Rep 2018;8:10746. [PMID: 30013128 DOI: 10.1038/s41598-018-28792-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
133 Weng CY, Xu JL, Sun SP, Wang KJ, Lv B. Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa. World J Gastroenterol 2021; 27(31): 5152-5170 [PMID: 34497441 DOI: 10.3748/wjg.v27.i31.5152] [Reference Citation Analysis]
134 Yang Z, Li W, He C, Xie C, Zhu Y, Lu NH. Potential effect of chronic Helicobacter pylori infection on glucose metabolism of Mongolian gerbils. World J Gastroenterol 2015; 21(44): 12593-12604 [PMID: 26640335 DOI: 10.3748/wjg.v21.i44.12593] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
135 Polyzos SA, Kountouras J, Zavos C, Deretzi G. Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease. Med Hypotheses 2014;82:795. [PMID: 24685365 DOI: 10.1016/j.mehy.2014.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]